Abstract:Significance statement: Racial and ethnic disparities in clinical trial enrollment are well described. However, whether these disparities are present in nephrology randomized clinical trials has not been previously reported. We performed a systematic review and meta-analysis of 380 randomized clinical trials involving different aspects of kidney disease published between 2000 and 2021. Our results indicate that worldwide reporting of race and ethnicity is poor and that White individuals account for most of the randomized participants with decreased enrollment of Black participants in more recent trials. However, trials conducted in the United States have representation of Black and Hispanic participants consistent with the population prevalence of disease and under-representation of Asian participants. Background: Under-representation of racial and ethnic minorities in clinical trials could worsen disparities, but reporting and enrollment practices in nephrology randomized clinical trials have not been described. Methods: PubMed was searched to capture randomized clinical trials for five kidney disease-related conditions published between 2000 and 2021 in ten high-impact journals. We excluded trials with <50 participants and pilot trials. Outcomes of interest were the proportion of trials reporting race and ethnicity and the proportions of enrolled participants in each race and ethnicity category. Results: Among 380 trials worldwide, race was reported in just over half and ethnicity in 12%. Most enrolled participants were White, and Black individuals accounted for ≤10% of participants except in dialysis trials where they accounted for 26% of participants. However, Black participants were enrolled at high proportions relative to disease and population prevalence in US CKD, dialysis, and transplant trials representing 19% of participants in AKI, 26% in CKD, 44% in GN, 40% in dialysis, and 26% in transplant trials. Enrollment of Asian participants was low worldwide except in GN trials with marked under-representation in US CKD, dialysis, and transplant trials. Hispanic individuals represented only 13% of participants in US dialysis trials compared with 29% of US dialysis population. Conclusion: More complete reporting of race and ethnicity in nephrology trials is needed. Black and Hispanic patients are well-represented in kidney disease trials in the United States. Asian patients are poorly represented in kidney trials both globally and in the United States.

Most UK cardiovascular disease trial protocols feature criteria that exclude ethnic minority participants: systematic review

Ethnic minority representation in UK COVID-19 trials: systematic review and meta-analysis

How inclusive were UK-based randomised controlled trials of COVID-19 vaccines? A systematic review investigating enrolment of Black adults and adult ethnic minorities

Ethnicity and Socioeconomic Disparities in Clinical Trial Participation for Ovarian Cancer: A Retrospective Observational Study in London

How to make cardiology clinical trials more inclusive

Inclusivity of patients in early phase breast cancer clinical trials

Effective interventions to increase representation of under-served groups in randomised trials in UK and Ireland: a scoping literature review

2051 How representative are UK-based trials investigating lifestyle interventions for diabetes mellitus: a systematic review

Recruitment, retention and reporting of variables related to ethnic diversity in randomised controlled trials: an umbrella review

A systematic review of ethnic minority participation in randomised controlled trials of systemic therapies for gynecological cancers

"We are not invited": Australian focus group results on how to improve ethnic diversity in trials

Racial and ethnic representation in peripheral artery disease randomized clinical trials

Representation of Racial and Ethnic Minorities in Nephrology Clinical Trials: A Systematic Review and Meta-Analysis

Reporting of participant ethnicity in paediatric randomised controlled trials in the UK

Barriers to Cardiac Rehabilitation in Ethnic Minority Groups: A Scoping Review

Twenty years of participation of racialised groups in type 2 diabetes randomised clinical trials: a meta-epidemiological review

Abstract WMP58: Underrepresentation of Racial and Ethnic Minorities in Stroke Clinical Trials

Consultations about randomised controlled trials are shorter and less in-depth for socioeconomically disadvantaged patients compared to socioeconomically advantaged patients: qualitative analysis across three trials

What are the ethnic inequities in care outcomes related to haematological malignancies, treated with transplant/cellular-therapies, in the UK?

Treatment resistant depression: A comparative study of access, pathways, and outcomes between Caucasian and ethnic minority individuals

Reporting and representation of underserved groups in intervention studies for patients with multiple long-term conditions: a systematic review